KVUE · Kenvue Inc.
$17.78
-0.06% last session
End-of-day data · close of 2026-09-11
Market cap
$34B
Enterprise value
$42B
Trailing P/E
20.9
Forward P/E
14.3
Dividend yield
5.0%
Beta
0.43
Avg volume
21M
Employees
22K
Daily Change %
-0.06%
5 Days Change
-5.28%
10 Days Change
-5.99%
30 Days Change
-5.79%
60 Days Change
-7.87%
Month to Day Change
-5.33%
Year to Day Change
6.51%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — KVUE
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-08-11
Latest call per bank · past 12 months
UBS
Neutral$19.00
+6.8% vs priceBarclays
Equal-Weight$19.00
+6.8% vs priceCitigroup
Neutral$19.00
+6.8% vs priceJefferies
Hold$18.00
+1.2% vs priceJP Morgan
Overweight$21.00
+18.0% vs priceBank of America
Buy$21.00
+18.0% vs priceGoldman Sachs
Neutral$19.00
+6.8% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-11 | UBS | Maintains | Neutral | $20.00 → $19.00 |
| 2026-07-21 | Barclays | Maintains | Equal-Weight | $18.00 → $19.00 |
| 2026-07-16 | UBS | Maintains | Neutral | $18.00 → $20.00 |
| 2026-04-15 | Citigroup | Maintains | Neutral | $20.00 → $19.00 |
| 2026-04-14 | Barclays | Maintains | Equal-Weight | $19.00 → $18.00 |
| 2026-04-07 | UBS | Maintains | Neutral | $19.00 → $18.00 |
| 2026-03-06 | Barclays | Maintains | Equal-Weight | $18.00 → $19.00 |
| 2026-02-18 | Canaccord Genuity | Maintains | Hold | $17.00 → $18.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 32 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 6.2% below the 50-day MA ($18.96).
- Price vs 200-day MA: Trading 0.8% above the 200-day MA ($17.64).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-0.16) — short-term momentum is fading.
- 52-week range: Price sits between the 52-week low ($13.46) and high ($19.61).
KVUE Price Chart
Loading chart for KVUE…
Fundamentals
About Kenvue Inc.
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
More in Household & Personal Products
PG
Procter & Gamble Company (The)
$332B 1.8% YTD
UL
Unilever PLC
$133B -2.0% YTD
CL
Colgate-Palmolive Company
$70B 13.4% YTD
EL
Estee Lauder Companies, Inc. (T
$35B -4.7% YTD
KMB
Kimberly-Clark Corporation
$33B 1.6% YTD
CHD
Church & Dwight Company, Inc.
$22B 14.6% YTD
CLX
Clorox Company (The)
$11B -7.9% YTD
ELF
e.l.f. Beauty, Inc.
$6B 31.6% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.